Riskpilot← Back to searchSign inGet full accessDANPROTEIN A/S
A/SActiveCVR 32893643Søllerødgårdsvej 11Business and other management consultancy activities · NACE 7020Est. 20102 employees
Revenue 2024
DKK 3M
+130% vs 2023
EBITDA margin
33.3%
+271% vs 2023
Equity ratio
75.8%
Financial strength
Net profit 2024
DKK -6,2M
-204% vs 2023
| Revenue | DKK 3M | +130% |
| EBITDA | DKK 988K | +271% |
| Net profit | DKK -6,2M | -204% |
| Total assets | DKK 63,3M | -5% |
| Equity | DKK 48M | -12% |
| Employees | 2 | — |
Legal name
DANPROTEIN A/S
CVR number
32893643
Legal form
Aktieselskab
NACE code
7020 · Business and other management consultancy activities
Founded
10. maj 2010
Share capital
DKK 500.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør, et bestyrelsesmedlem i forening med én direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med produktion, handel, investering og holdingvirksomhed samt hermed efter bestyrelsens skøn beslægtet virksomhed.
Address
Søllerødgårdsvej 11
Phone
+4574420138
Email
pth@danfond.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | -107 | 910 | 941 | 620 | 1.028 | 896 | 2.743 | 3.379 | 3.091 | -1.030 | 1.858 | 1.288 | 2.969 |
| Staff expenses | -0 | -0 | -138 | -138 | -139 | -263 | -358 | -757 | -2.133 | -2.434 | -2.436 | -2.018 | -2.394 | -1.865 | -1.980 |
| EBITDA | — | — | -245 | 772 | 801 | 357 | 670 | 139 | 611 | 945 | 655 | -3.073 | -537 | -577 | 988 |
| Depreciation & amort. | -0 | -0 | -0 | -44 | -181 | -100 | -231 | -182 | -194 | -197 | -194 | -182 | -100 | -107 | -111 |
| EBIT | — | — | -245 | 727 | 620 | 256 | 440 | -42 | 417 | 748 | 462 | -3.256 | -636 | -684 | 877 |
| Net financials | 0 | 0 | 7.146 | 6.795 | 5.586 | 6.521 | 7.213 | 5.826 | 1.444 | 4.829 | 3.529 | 4.319 | 3.447 | 6.728 | -6.912 |
| Profit before tax | — | — | 6.901 | 7.522 | 6.207 | 6.778 | 7.653 | 5.784 | 1.861 | 5.577 | 3.990 | 1.063 | 2.811 | 6.044 | -6.034 |
| Tax | -0 | -0 | -41 | 149 | 85 | -174 | 190 | -216 | -486 | 653 | 6 | -445 | -189 | 84 | 193 |
| Net profit | — | — | 6.941 | 7.373 | 6.122 | 6.951 | 7.462 | 6.000 | 2.348 | 4.925 | 3.984 | 1.508 | 3.000 | 5.960 | -6.227 |
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 0 | 0 | 18.249 | 34.463 | 36.285 | 48.708 | 46.949 | 52.806 | 57.028 | 49.167 | 59.356 | 50.541 | 52.198 | 66.804 | 63.266 |
| Equity | — | — | 15.694 | 22.797 | 28.641 | 35.503 | 38.965 | 44.464 | 42.812 | 45.737 | 45.698 | 46.204 | 49.205 | 54.682 | 47.962 |
| Long-term debt | 0 | 0 | 0 | 1.362 | 1.331 | 1.300 | 2.861 | 2.770 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 2.555 | 10.304 | 6.313 | 11.906 | 5.122 | 5.571 | 14.212 | 3.417 | 13.627 | 4.337 | 2.993 | 12.106 | 15.277 |
| Total debt | 0 | 0 | 2.555 | 11.666 | 7.644 | 13.206 | 7.984 | 8.341 | 14.212 | 3.417 | 13.627 | 4.337 | 2.993 | 12.106 | 15.277 |
EBITDA margin
33.3%
This company
15.8%
Market median
+111% vs market
20102024
Equity ratio
75.8%
This company
38.2%
Market median
+98% vs market
20102024
Return on equity
-13.0%
This company
18.4%
Market median
-171% vs market
20102024
Net profit margin
-209.8%
This company
8.1%
Market median
-2690% vs market
20102024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20102024
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20102024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via CVR / Virk · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via CVR / Virk · Period 2010-05-10 – 2010-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PT Founder | Founder | 2010 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2012 | — | — | |
| Chairman | 2010 | — | — | |
| Chairman | 2016 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2010 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2011 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DANPROTEIN A/S (this company)
Danfond RF ApSBoard members of DANPROTEIN A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Theiss Holm | Founder | 0 companies |
| Anna Charlotta Holm | Chairman | 0 companies |
| Hans Henrik Wurlitzer | Chairman | 0 companies |
| Jørgen Meyer | Chairman | 0 companies |
| Ole Bjerre Christiansen | Board of Directors | 0 companies |
| Gurli Bartholin | Board of Directors | 0 companies |